Back

Differences in non-flow limiting non-culprit plaque characteristics after myocardial infarction in patients with versus without chronic kidney disease

2 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Multivessel disease in acute coronary syndromes Angiography, Invasive Imaging ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Rick Volleberg

Radboud University Medical Centre, Nijmegen (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Complete revascularisation versus culprit lesion only PCI in patients with non-ST-elevation myocardial infarction and multivessel disease.
Mr Y. Hung (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial
Doctor P. Morris (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
Complete vs culprit-lesion-only myocardial revascularization in patients with out-of-hospital cardiac arrest: insights from the multicentric "Lombardia CARe" registry
Doctor L. Raone (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Impact of microvascular resistance reserve on post-STEMI cardiac remodelling and diastolic function
Doctor T. Tsai (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Real-life impact of complete revascularization of non-ST elevation myocardial infarction during index hospitalization
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Multivessel disease in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of chronic kidney disease on patients with Myocardial Infarction with Non Obstructive Coronary Arteries (MINOCA)
thumbnail
Congress Presentation
Non-flow limiting non-culprit plaque characteristics in patients presenting with STEMI versus NSTEMI
thumbnail
Congress Presentation
Impact of macrovascular and microvascular cardiac disease assessed by 82-rubidium positron emission tomography in patients with chronic kidney disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources